Latest Conference Articles

Hyperglycemia among noncritically ill medical and surgical patients is a huge problem in hospitals throughout the United States.

A variety of rapid and reliable tests now exist to diagnose and facilitate the management of pheochromocytoma and primary aldosteronism, but more are needed.

The AACE highlighted a number of studies on a wide range of endocrinology topics from adrenal disorders to metabolic bone disease.

The AACE highlighted a number of studies on a wide range of endocrinology topics from adrenal disorders to metabolic bone disease.

In a preliminary study, Attiva, increased the post-meal feeling of satiety and reduced hunger between meals.

The efficacy of liraglutide,is not impacted in subjects with type 1 diabetes who develop anti-liraglutide antibodies.

Colesevelam HCL is effective not only in lowering LDL-cholesterol but in reducing glycemic levels in people with prediabetes.

Here you will find links to information about the general session presentations, satellite symposia, and poster presentations scheduled for the meeting.

Conference attendees who are looking for places to eat and things to do while in Boston, here is a listed of suggestions.

New research released today at the AACE Meeting indicates another reason to avoid fast food; it may also be lacking in appropriate amounts of iodine.

CGMs can be helpful in managing patients with type 2 diabetes or any diabetes patient in the hospital setting, according to several experts.

The varying impact of insulin resistance on different tissues in the human body may lead to a better understanding of metabolic syndrome.

While hyperglycemia is a risk factor for microvascular complications, most patients die of macrovascular disease, which is strongly influenced by dyslipidemia.

Thyroid cancer is one of the fastest growing cancers in the United States, especially in women, according to Bryan Haugen, MD.

There is a new drug treatment strategy coming down the pipeline for diabetes, one that targets the kidney.

A novel mitral valve clip was proven to be as safe and effective as open-chest surgery in selected patients with mitral valve regurgitation.

Three studies examine a treatment, a diagnostic, and the risk of thromboembolism after pelvic surgery, respectively.

Moroney and colleagues discussed the preliminary results of a novel phase I combination of liposomal doxorubicin, bevacizumab, and temsirolimus.

A study provided evidence that certain tumors can safely be monitored with ultrasound for years without raising the risk of ovarian cancer.

During the the National Comprehensive Cancer Network 15th Annual Conference, updates were presented for various NCCN Clinical Practice Guidelines.

Many cancers increase the risk of other serious events and many treatments have their own risks and adverse effects that must be managed.

NCCN is increasingly collaborating with other nations to develop foreign editions of its guidelines.

Women with uterine cancer who are treated with laparoscopy have a 3-year rate of overall survival similar to that of women who undergo traditional laparotomy.

Some patients with ovarian cancer benefit from adding a taxane to a platinum-based chemotherapy, but the regimen presents increased risk.

When adolescents and young adults develop cancer, clinicians contend with an entirely different set of considerations in treatment and follow-up.

Gynecologic oncologists are advancing a treatment method that shows great promise in extending PFS and OS for women with certain advanced gynecologic cancers.

Ware and associates described a multi-institutional experience that examined the American Society of Obstetricians referral guidelines for a pelvic mass.